{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T20:40:28Z","timestamp":1716496828953},"reference-count":15,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Med. Chem."],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.4155\/fmc.11.103","type":"journal-article","created":{"date-parts":[[2011,8,22]],"date-time":"2011-08-22T16:20:32Z","timestamp":1314030032000},"page":"1235-1237","source":"Crossref","is-referenced-by-count":2,"title":["Drugs for Neglected Diseases: Part I"],"prefix":"10.1080","volume":"3","author":[{"given":"Takushi","family":"Kaneko","sequence":"first","affiliation":[{"name":"Global Alliance for TB Drug Development, 40 Wall Street, 24th Floor, NY10005, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,8,22]]},"reference":[{"key":"e_1_3_3_2_1_1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.06.031955"},{"key":"e_1_3_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.3201\/eid1406.071266"},{"key":"e_1_3_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio837"},{"key":"e_1_3_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000718"},{"key":"e_1_3_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.11.86"},{"key":"e_1_3_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.11.83"},{"key":"e_1_3_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.11.82"},{"key":"e_1_3_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.11.87"},{"key":"e_1_3_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.11.80"},{"key":"e_1_3_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.11.92"},{"key":"e_1_3_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.11.77"},{"key":"e_1_3_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.4155\/fmc.11.85"},{"key":"e_1_3_3_3_2_1","unstructured":"WHO. Neglected diseases: a human rights analysis. http:\/\/apps.who.int\/tdr\/svc\/publications\/tdr-research-publications\/neglected-diseases-human-right-analysis"},{"key":"e_1_3_3_3_3_1","unstructured":"WHO. Special Programme for Research and Training in Tropical Diseases. http:\/\/apps.who.int\/tdr"},{"key":"e_1_3_3_3_4_1","unstructured":"Oxfam Briefing Paper. Ending the R7D crisis in public health: promoting pro-poor medical innovation. www.oxfam.org.nz\/resources\/onlinereports\/bp122-randd-crisis-public-health.pdf"}],"container-title":["Future Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fmc.11.103","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T19:49:14Z","timestamp":1716493754000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fmc.11.103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":15,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["10.4155\/fmc.11.103"],"URL":"https:\/\/doi.org\/10.4155\/fmc.11.103","relation":{},"ISSN":["1756-8919","1756-8927"],"issn-type":[{"value":"1756-8919","type":"print"},{"value":"1756-8927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}